Pharmaceutical industry tactics could be blocking generic drugs

By Helen Crump2008-12-04T01:00:00

The European Commission has uncovered a 'tool box' of pharmaceutical company strategies that may be delaying availability of cheaper generic alternatives to costly patented medicines.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here